MCL1 underexpression
|
Small Cell Lung Cancer
|
MCL1 underexpression
|
Small Cell Lung Cancer
|
cisplatin Sensitive: C3 – Early Trials
|
cisplatin Sensitive: C3 – Early Trials
|
MCL1 underexpression
|
Multiple Myeloma
|
MCL1 underexpression
|
Multiple Myeloma
|
venetoclax Sensitive: D – Preclinical
|
venetoclax Sensitive: D – Preclinical
|
MCL1 underexpression
|
Multiple Myeloma
|
MCL1 underexpression
|
Multiple Myeloma
|
bortezomib + A-1331852 Sensitive: D – Preclinical
|
bortezomib + A-1331852 Sensitive: D – Preclinical
|
MCL1 underexpression
|
T Acute Lymphoblastic Leukemia
|
MCL1 underexpression
|
T Acute Lymphoblastic Leukemia
|
venetoclax + BI 6727 Sensitive: D – Preclinical
|
venetoclax + BI 6727 Sensitive: D – Preclinical
|